SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019085
Filing Date
2022-05-10
Accepted
2022-05-10 08:11:02
Documents
57
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prld-10q_20220331.htm   iXBRL 10-Q 3377830
2 EX-10.1 prld-ex101_194.htm EX-10.1 82986
3 EX-31.1 prld-ex311_6.htm EX-31.1 22739
4 EX-31.2 prld-ex312_7.htm EX-31.2 22764
5 EX-32.1 prld-ex321_9.htm EX-32.1 10238
6 EX-32.2 prld-ex322_8.htm EX-32.2 10326
  Complete submission text file 0001564590-22-019085.txt   8208933

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA prld-20220331.xsd EX-101.SCH 38849
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prld-20220331_cal.xml EX-101.CAL 36446
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prld-20220331_def.xml EX-101.DEF 149390
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prld-20220331_lab.xml EX-101.LAB 329196
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prld-20220331_pre.xml EX-101.PRE 248814
51 EXTRACTED XBRL INSTANCE DOCUMENT prld-10q_20220331_htm.xml XML 1150337
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39527 | Film No.: 22907476
SIC: 2834 Pharmaceutical Preparations